Ameritas Investment Partners’s Cabaletta Bio CABA Stock Holding History

Ameritas Investment Partners’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,452	Closed	-$4.78K	–	3219
2025 Q1	$4.78K	Hold	3,452	–	–	﹤0.01%	2979
2024 Q4	$7.84K	Hold	3,452	–	–	﹤0.01%	2961
2024 Q3	$16.3K	Hold	3,452	–	–	﹤0.01%	2739
2024 Q2	$25.8K	Hold	3,452	–	–	﹤0.01%	2505
2024 Q1	$58.9K	Hold	3,452	–	–	﹤0.01%	2053
2023 Q4	$78.4K	Hold	3,452	–	–	﹤0.01%	1900
2023 Q3	$52.5K	Buy	3,452 +1,340	+63%	+$18.3K	﹤0.01%	2077
2023 Q2	$27.3K	Buy	+2,112	New	+$22.9K	﹤0.01%	2394
2021 Q2	–	Sell	-1,125	Closed	-$12K	–	3077
2021 Q1	$12K	Hold	1,125	–	–	﹤0.01%	2768
2020 Q4	$14K	Hold	1,125	–	–	﹤0.01%	2640
2020 Q3	$12K	Buy	1,125 +565	+101%	+$6.49K	﹤0.01%	2623
2020 Q2	$6K	Hold	560	–	–	﹤0.01%	2911
2020 Q1	$4K	Hold	560	–	–	﹤0.01%	2861
2019 Q4	$8K	Buy	+560	New	+$6.64K	﹤0.01%	2798

Other funds holding CABA

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Ameritas Investment Partners's CABA Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Cabaletta Bio (CABA) in Q2 2025, closing a stake of 3,452 shares — an estimated $4.78K sold.

Ameritas Investment Partners first reported a position in CABA in Q4 2019 and held it in 14 quarters. The position peaked at $78.4K in Q4 2023. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2025.

Ameritas Investment Partners reported no remaining Cabaletta Bio position as of Q2 2025 after selling out during the quarter.
Ameritas Investment Partners sold 3,452 Cabaletta Bio shares in Q2 2025, an estimated $4.78K.
Ameritas Investment Partners first reported a position in Cabaletta Bio in Q4 2019 and held it in 14 quarters.
Ameritas Investment Partners's Cabaletta Bio position peaked at $78.4K in Q4 2023.
86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.